PlainRecalls
FDA Drug Moderate Class II Terminated

HYDROMORPHONE 0.2MG/ML IN NACL 0.9% SYR (C-II) , [a) 50 ML NDC 70731-0114-89; b) 55 ML NDC 70731-0114-95] per syringe, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701.

Reported: August 14, 2019 Initiated: June 19, 2019 #D-1665-2019

Product Description

HYDROMORPHONE 0.2MG/ML IN NACL 0.9% SYR (C-II) , [a) 50 ML NDC 70731-0114-89; b) 55 ML NDC 70731-0114-95] per syringe, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701.

Reason for Recall

Lack of Assurance of Sterility

Details

Recalling Firm
RXQ Compounding LLC
Units Affected
N/A
Distribution
Nationwide USA
Location
Athens, OH

Frequently Asked Questions

What product was recalled?
HYDROMORPHONE 0.2MG/ML IN NACL 0.9% SYR (C-II) , [a) 50 ML NDC 70731-0114-89; b) 55 ML NDC 70731-0114-95] per syringe, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701.. Recalled by RXQ Compounding LLC. Units affected: N/A.
Why was this product recalled?
Lack of Assurance of Sterility
Which agency issued this recall?
This recall was issued by the FDA Drug on August 14, 2019. Severity: Moderate. Recall number: D-1665-2019.